Thursday, July 13, 2023

Media Tip Sheet: Ecology of the Pacific Northwest and the Cascadia Bioregion


Featured presentations at the 108th Annual Meeting of the Ecological Society of America in Portland, Oregon

Meeting Announcement

ECOLOGICAL SOCIETY OF AMERICA




Dozens of sessions at the Ecological Society of America’s upcoming Annual Meeting in Portland, Oregon, Aug. 6-11, will feature research on the ecology of the geographic and environmental region surrounding the conference venue: the Pacific Northwest and Cascadia Bioregion, which encompass a vast area stretching from northern California to southern Alaska.

The Pacific Northwest’s temperate rainforests are home to old-growth conifers and multiple threatened and endangered species. Its diverse marine and coastal environments host whales, puffins and vibrant kelp forests. The annual salmon runs in the region’s rivers sustain ecosystems and provide cultural significance. These landscapes and rich ecological communities provide an invaluable platform for scientific inquiry – and also face numerous environmental challenges.

The talks and posters listed below will be presented at the Ecological Society of America’s upcoming Annual Meeting, August 6-11, 2023. ESA invites staff journalists, freelance journalists, student journalists and press officers to register for free as media attendees up to and throughout the week of the Annual Meeting. For eligibility information, please visit ESA’s press registration credential policy page. Members of the media will be able to attend all scientific sessions at the conference and will have access to a press room where they can enjoy refreshments, internet access, a printer and an interview area.

For a longer list of presentations focused on the ecology of the Pacific Northwest and Cascadia Bioregion, please visit the full web version of this tip sheet.

Monday, August 7

2:00 PM - 2:15 PM

Restoration islands as a conservation tool: the case for the imperiled greater sage-grouse
Presenter: Scott Harris, Institute for Applied Ecology
Contributed Talk - COS 21

4:30 PM - 4:45 PM

Widespread foliage scorch in the wake of the 2021 heat dome heat wave in the Pacific Northwest: patterns, drivers of vulnerability, and lessons for future heatwaves
Presenter: Adam Sibley, Oregon State University
Contributed Talk - COS 31

5:00 PM - 6:30 PM

Drivers shaping plant communities recovering from disturbance at Mount St. Helens
Presenter: Tommy Conway, Washington State University
Contributed Poster

 

Tuesday, August 8

8:15 AM - 8:30 AM

A decade of beaver relocation led by the Tulalip Tribes: lessons learned and next steps
Presenter: Molly Alves, Utah State University/Tulalip Tribes
Organized Oral Session - OOS 13

9:15 AM - 9:30 AM

When the Black Swan shows up: the unprecedented but also totally precedented 2020 Labor Day fire event in the West Cascades
Presenter: Daniel Donato, Washington State Department of Natural Resources
Organized Oral Session - OOS 17

3:45 PM - 4:00 PM

Climate change effects on phenology of anadromous salmonids in Coastal Riverscapes of the Pacific Northwest
Presenter: Rebecca Flitcroft, USDA Forest Service, Pacific Northwest Research Station
Organized Oral Session - OOS 28

 

Wednesday, August 9

8:15 AM - 8:30 AM

Practices and Principles of Partnering with Tribal Nations in the Pacific Northwest Using Indigenous Knowledge (IK) to Restore Forest Resiliency to Wildfire and Climate Change
Presenter: Cristina Eisenberg, Oregon State University
Contributed Talk - COS 149

10:20 AM - 10:40 AM

Forest resilience to fire and interacting disturbances in the northwest US in a period of rapid change
Presenter: Brian J. Harvey, University of Washington
Symposium (In Person) - SYMP 16

3:30 PM - 3:45 PM

Divergent values and perspectives drive three distinct viewpoints on grizzly bear reintroduction in Washington, USA
Presenter: Anna Santo, University of British Columbia
Contributed Talk - COS 208

 

Thursday, August 10

10:15 AM - 10:30 AM

Ecological factors impacting distribution of ticks and tick-borne disease in Washington State
Presenter: Elizabeth Dykstra, Washington State Department of Health
Organized Oral Session - OOS 55

10:20 AM - 10:40 AM

Co-creating aquatic knowledge with and for Indigenous communities
Presenter: Danielle Ignace, The University of British Columbia
Symposium (In Person) - SYMP 24

3:45 PM - 4:00 PM

Lichen and moss bioindicators of air quality in the U.S. Forest Inventory: from forests to high elevation wilderness and urban neighborhoods
Presenter: Sarah Jovan, USDA Forest Service
Organized Oral Session - OOS 64

 

###

The Ecological Society of America, founded in 1915, is the worlds largest community of professional ecologists and a trusted source of ecological knowledge, committed to advancing the understanding of life on Earth. The 9,000 member Society publishes five journals and a membership bulletin and broadly shares ecological information through policy, media outreach, and education initiatives. The Society’s Annual Meeting attracts 4,000 attendees and features the most recent advances in ecological science. Visit the ESA website at https://www.esa.org.

For more information about the Ecological Society of America, visit www.esa.org or find us on FacebookTwitterLinkedInInstagram and YouTube.

Ketamine effective for treatment-resistant depression: clinical trial


Peer-Reviewed Publication

UNIVERSITY OF NEW SOUTH WALES




A low-cost version of ketamine to treat severe depression has performed strongly in a double-blind trial that compared it with placebo.

In research published today in the British Journal of Psychiatry, researchers led by UNSW Sydney and the affiliated Black Dog Institute found that more than one in five participants achieved total remission from their symptoms after a month of bi-weekly injections, while a third had their symptoms improve by at least 50 per cent. The study was a collaboration between six academic clinical mood disorder units in Australia and one in New Zealand and was funded by the Australian National Health and Medical Research Council (NHMRC).

“For people with treatment-resistant depression – so those who have not benefitted from different modes of talk-therapy, commonly prescribed antidepressants, or electroconvulsive therapy – 20 per cent remission is actually quite good,” lead researcher Professor Colleen Loo says.

“We found that in this trial, ketamine was clearly better than the placebo – with 20 per cent reporting they no longer had clinical depression compared with only 2 per cent in the placebo group. This is a huge and very obvious difference and brings definitive evidence to the field which only had past smaller trials that compared ketamine with placebo.”

How the trial worked

The researchers recruited 179 people with treatment-resistant depression. All were given an injection of either a generic form of ketamine that is already widely available in Australia as a drug for anaesthesia and sedation – or placebo. Participants received two injections a week in a clinic where they were monitored for around two hours while acute dissociative and sedative effects wore off – usually within the first hour. The treatment ran for a month and participants were asked to assess their mood at the end of the trial and one month later.

As a double-blind trial, neither participants nor researchers administering the drug were aware which patients received generic ketamine or placebo, to ensure psychological biases were minimised. Importantly, a placebo was chosen that also causes sedation, to improve treatment masking. Midazolam is a sedative normally administered before a general anaesthetic, while in many previous studies the placebo was saline.

“Because there are no subjective effects from the saline, in previous studies it became obvious which people were receiving the ketamine and which people received placebo,” Prof. Loo says.

“In using midazolam – which is not a treatment for depression, but does make you feel a bit woozy and out of it – you have much less chance of knowing whether you have received ketamine, which has similar acute effects.”

Other features of the recent trial that set it apart from past studies included accepting people into the trial who had previously received electroconvulsive therapy (ECT).

“People are recommended ECT treatment for their depression when all other treatments have been ineffective,” Prof. Loo says.

“Most studies exclude people who have had ECT because it is very hard for a new treatment to work where ECT has not.”

Another difference about this trial was that the drug was delivered subcutaneously (injected into the skin) rather than by drip, thus greatly reducing time and medical complexity. The study is also the largest in the world to date that compares generic ketamine with placebo in treating severe depression.

Much more affordable

Apart from the positive results, one of the standout benefits of using generic ketamine for treatment-resistant depression is that it is much cheaper than the patented S-ketamine nasal spray currently in use in Australia. Where S-ketamine costs about $800 per dose, the generic ketamine is a mere fraction of that, costing as little as $5, depending on the supplier and whether the hospital buys it wholesale. On top of the cost for the drug, patients need to pay for the medical care they receive to ensure their experience is safe – which at Black Dog Institute clinics, comes to $350 per session.

“With the S-ketamine nasal spray, you are out of pocket by about $1200 for every treatment by the time you pay for the drug and the procedure, whereas for generic ketamine, you're paying around $300-350 for the treatment including the drug cost,” Prof. Loo says.

She adds that for both S-ketamine and generic ketamine treatments, the positive effects often wear off after a few days to weeks, so ongoing treatment may be required, depending on someone’s clinical situation. But the prohibitive costs of the drug and procedure make this an unsustainable proposition for most Australians.

“This is why we're applying for a Medicare item number to fund this treatment now, because it’s such a powerful treatment.

“And if you consider that many of these people might spend many months in hospital, or be unable to work and are often quite suicidal, it’s quite cost effective when you see how incredibly quickly and powerfully it works. We’ve seen people go back to work, or study, or leave hospital because of this treatment in a matter of weeks.”

The researchers will next be looking at larger trials of generic ketamine over longer periods, and refining the safety monitoring of treatment.

ENDS

Participating trial sites

  • UNSW / Black Dog Institute
  • Royal Prince Alfred Hospital / University of Sydney
  • NeuroCentrix Research Institute
  • Royal Adelaide Hospital / University of Adelaide
  • Monash Alfred Psychiatry Research Centre / Monash University
  • University of Otago
  • Gold Coast University Hospital

 

Institutions of non-site collaborators

  • Deakin University
  • University of Newcastle
  • The George Institute for Global Health
  • University of Western Australia

New book explores the psychology of being duped


Nobody's Fool: Why We Get Taken In and What We Can Do About It

Book Announcement

UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN, NEWS BUREAU

Daniel Simons 

IMAGE: ILLINOIS PSYCHOLOGY PROFESSOR DANIEL SIMONS STUDIES VISUAL COGNITION, PERCEPTION, ATTENTION AND MEMORY. HE IS THE CO-AUTHOR, WITH CHRISTOPHER CHABRIS, OF “NOBODY’S FOOL: WHY WE GET TAKEN IN AND WHAT WE CAN DO ABOUT IT.” view more 

CREDIT: PHOTO BY SHANNON SILFER




CHAMPAIGN, Ill. — According to two psychologists who study memory and perception, fraudsters tend to exploit the common habits of thought and decision-making that make us susceptible – and often oblivious – to their fabrications. Their book, “Nobody’s Fool: Why We Get Taken In and What We Can Do About It,” gives readers an overview of dozens of types of scams, hoaxes and strategies used by cheaters to deceive, and explains how to evaluate their ploys and avoid becoming a victim.

Watch a video about the book.

The authors, Daniel Simons, a professor of psychology at the University of Illinois Urbana-Champaign, and Christopher Chabris, a cognitive scientist who has taught at Union College and Harvard University, are already known for “The Invisible Gorilla,” a book that explored the limits of human perception with studies showing that intense focus on one kind of stimulus can blind us to other obvious details of a scene.

Their new book shows how common psychological habits can get us into trouble when we become the target of efforts to deceive us. The human tendency to trust seemingly familiar sources or information we have seen repeatedly, the assumption that consistency is a mark of integrity, our tendency to overvalue our assumptions without checking them carefully, and our reluctance to ask more questions – these and other traits can make us easier to fool.

“Nobody’s Fool” gives numerous examples of the mechanisms driving fraudulent scientific reports, Ponzi schemes, phishing attacks, computer-assisted cheating, art forgery, and deceptive political and business practices. Such trickery can rob us of our access to reliable information, fair elections and, of course, our money.

All of these scams rely on common human psychological tendencies, the authors write. For example, we have a basic tendency to believe that what other people tell us is true.

“Truth bias is a feature, not a bug,” they write. Most people are honest most of the time, so it makes sense that we do not question every statement from every person we encounter.

“But truth bias is also an overarching factor that plays a role in every con, scam and fraud,” they add. This leaves us with a conundrum: “We need to believe others, but if we trust too much, we’re in trouble – especially now.”

The book urges readers to engage in a number of practices that will help them navigate murky waters and avoid being scammed. These include accepting less of what they’re told – even by friends and close acquaintances – and checking the facts more often, especially when making big decisions. The authors urge readers to ask more questions, be wary when they’re told something that perfectly fits what they believe and expect to hear, and pay attention to what isn’t said or isn’t included in demonstrations or presentations.

The authors also describe how easy explanations, perfect results or a lack of at least some random variation in the data offered to support a particular conclusion should all be viewed as red flags by anyone hoping to ferret out deceit.

Throughout the book, the authors provide examples of the sorts of questions we can ask ourselves – and others – to make sure that our habits are working for us rather than for people looking to cheat us.

Book cover design: Chin-Yee Lai; Image: Michael Burrell/Alamy; Jacket © 2023 Hachette Book Group, Inc. 

“Nobody’s Fool: Why We Get Taken In and What We Can Do About It” is available from Basic Books.

Hardcover: 336 pages
ISBN-10: 1541602234, ISBN-13: 978-1541602236
Kindle: ASIN: B0BLNDRL8V
Audible: ASIN: B0BLXBGWRB
Audio COULD: ISBN-10: 1668635984, ISBN-13: 978-1668635988

Fear is in the eye of the beholder


A cluster of neurons in the brains of fruit flies has been found to control visual aversion to scary objects


Peer-Reviewed Publication

UNIVERSITY OF TOKYO

GIF: Visual fear aversion. 

VIDEO: CALM FLIES WOULDN’T SHOW A CHANGE IN BEHAVIOR IN RESPONSE TO A VISUAL OBJECT, BUT FEARFUL FLIES WOULD RUN AWAY FROM IT. view more 

CREDIT: 2023, TSUJI ET AL.




Averting our eyes from things that scare us may be due to a specific cluster of neurons in a visual region of the brain, according to new research at the University of Tokyo. Researchers found that in fruit fly brains, these neurons release a chemical called tachykinin which appears to control the fly’s movement to avoid facing a potential threat. Fruit fly brains can offer a useful analogy for larger mammals, so this research may help us better understand our own human reactions to scary situations and phobias. Next, the team want to find out how these neurons fit into the wider circuitry of the brain so they can ultimately map out how fear controls vision.

Do you cover your eyes during horror movies? Or perhaps the sight of a spider makes you turn and run? Avoiding looking at things which scare us is a common experience, for humans and animals. But what actually makes us avert our gaze from the things we fear? Researchers have found that it may be due to a group of neurons in the brain which regulates vision when feeling afraid.

“We discovered a neuronal mechanism by which fear regulates visual aversion in the brains of Drosophila (fruit flies). It appears that a single cluster of 20-30 neurons regulates vision when in a state of fear. Since fear affects vision across animal species, including humans, the mechanism we found may be active in humans as well,” explained Assistant Professor Masato Tsuji from the Department of Biological Sciences at the University of Tokyo.

The team used puffs of air to simulate a physical threat and found that the flies’ walking speed increased after being puffed at. The flies also would choose a puff-free route if offered, showing that they perceived the puffs as a threat (or at least preferred to avoid them). Next the researchers placed a small black object, roughly the size of a spider, 60 degrees to the right or left of the fly. On its own the object didn’t cause a change in behavior, but when placed following puffs of air, the flies avoided looking at the object and moved so that it was positioned behind them.

To understand the molecular mechanism underlying this aversion behavior, the team then used mutated flies in which they altered the activity of certain neurons. While the mutated flies kept their visual and motor functions, and would still avoid the air puffs, they did not respond in the same fearful manner to visually avoid the object.

“This suggested that the cluster of neurons which releases the chemical tachykinin was necessary for activating visual aversion,” said Tsuji. “When monitoring the flies’ neuronal activity, we were surprised to find that it occurred through an oscillatory pattern, i.e., the activity went up and down similar to a wave. Neurons typically function by just increasing their activity levels, and reports of oscillating activity are particularly rare in fruit flies because up until recently the technology to detect this at such a small and fast scale didn’t exist.”

By giving the flies genetically encoded calcium indicators, the researchers could make the flies' neurons shine brightly when activated. Thanks to the latest imaging techniques, they then saw the changing, wavelike pattern of light being emitted, which was previously averaged out and missed.

Next, the team wants to figure out how these neurons fit into the broader circuitry of the brain. Although the neurons exist in a known visual region of the brain, the researchers do not yet know from where the neurons are receiving inputs and to where they are transmitting them, to regulate visual escape from objects perceived as dangerous.  

“Our next goal is to uncover how visual information is transmitted within the brain, so that we can ultimately draw a complete circuit diagram of how fear regulates vision,” said Tsuji.  “One day, our discovery might perhaps provide a clue to help with the treatment of psychiatric disorders stemming from exaggerated fear, such as anxiety disorders and phobias.”

#####

Paper Title:

Masato Tsuji, Yuto Nishizuka, Kazuo Emoto. Threat gates visual aversion via theta activity in Tachykinergic neurons. Nature Communications. doi: 10.1038/s41467-023-39667-z

Funding

This research was supported by the Japan Society for the Promotion of Science (JSPS) through the Graduate Program for Leaders in Life Innovation (GPLLI), MEXT Grants-in-Aid for Scientific Research on Innovative Areas “Dynamic regulation of brain function by Scrap and Build system” (KAKENHI 16H06456), JSPS (KAKENHI 16H02504), WPI-IRCN, AMED-CREST (JP21gm1310010), JST-CREST (JPMJCR22P6), Toray Foundation, Naito Foundation, Takeda Science Foundation, and Uehara Memorial Foundation.

Useful Links

Graduate School of Science: https://www.s.u-tokyo.ac.jp/en/

International Research Center for Neurointelligence: https://ircn.jp/en/

About the University of Tokyo
The University of Tokyo is Japan's leading university and one of the world's top research universities. The vast research output of some 6,000 researchers is published in the world's top journals across the arts and sciences. Our vibrant student body of around 15,000 undergraduate and 15,000 graduate students includes over 4,000 international students. Find out more at www.u-tokyo.ac.jp/en/ or follow us on Twitter at @UTokyo_News_en.

People with more empathy more likely to support international sharing of coronavirus vaccines, study shows


Peer-Reviewed Publication

UNIVERSITY OF EXETER




People with more empathy and cosmopolitan beliefs are more likely to support the international sharing of coronavirus vaccines, a new study shows. 

During the COVID-19 pandemic, many residents of high-income countries were eligible for COVID-19 vaccine boosters, while many residents of lower-income countries had not yet received a first dose.  

Researchers analysed the levels and predictors of international vaccine solidarity through a survey of around 2,000 German adults in the autumn of 2021. They measured their preferences for sharing vaccine supplies internationally versus using that supply as boosters for the domestic population.  

Almost half – 48 per cent – prioritised giving doses to citizens in less developed countries. A third of respondents preferred to use available doses as boosters domestically, and a fifth of respondents (19 per cent) did not report a preference.  

Respondents were asked: "Coping with the COVID-19 pandemic requires difficult decisions. By the end of September, about 64 percent of people eligible for vaccination had been vaccinated at least once. What do you think is the more important priority now for the use of Germany’s vaccine stocks: offering a third vaccine dose ("booster vaccination") to people in Germany or giving vaccine stocks for first and second vaccine doses to less developed countries?" 

The survey was fielded when the number of daily COVID-19 cases was decreasing, but before the Omicron variant was discovered. The supply of booster shots was still limited both within Germany and much more so globally. Booster shots were only available to larger groups of the population later in Germany.  

Relative to SPD (Social Democrats) supporters, respondents who identified with the conservative CDU showed less support for international vaccine solidarity. Individuals who identified with the Green Party showed more support for dose sharing. 

The study was carried out by Florian Stoeckel, Paula Szewach, Jason Reifler and Jack Thompson, from the University of Exeter, Sabrina Stöckli, from the University of Bern and University of Zurich, Matthew Barnfield from the University of Essex, Joseph B. Phillips from the University of Kent, Benjamin Lyons from the University of Utah, Vittorio Mérola from Durham University 

Dr Stoeckel said: “We found that a plurality prefer sharing doses of the COVID-19 vaccine internationally over keeping them in the host country. This highlights that politicians might have some room to manoeuvre and fulfil international vaccine sharing pledges. 

“Our result is particularly noteworthy given that international vaccine sharing, at the time of the survey, was not a prominent part of public discourse, which was mostly focused on national vaccine uptake. It is also important to note that almost one in five respondents had no view, leaving room for opinions to crystallise. There seems to be potential for more international vaccine sharing and for communication that increases the salience of the issue, which could mobilize further support.” 

Those who scored higher on empathy and those who support domestic redistribution were more inclined to support redistributing vaccines internationally. To the extent that German citizens think about vaccine solidarity, they treated it like a typical foreign aid issue.  

Older respondents – the group most at risk to COVID-19 – did not consistently show less support for vaccine solidarity, researchers have found. 

Dr Stoeckel said: “We found there is substantial public support among citizens to share doses internationally at least when infection rates are at a modest level and falling. The COVID-19 pandemic is hopefully over, but international inequality when it comes to access to medical supplies is an ongoing global challenge. We hope to contribute to the discussion on ways how these challenges can be addressed.” 

Artificially grown ‘mini-brains’ without animal components bring opportunities for neuroscience


Novel method will make it easier for translational research to leap from the lab to the clinic, researchers say

Peer-Reviewed Publication

MICHIGAN MEDICINE - UNIVERSITY OF MICHIGAN




Researchers at University of Michigan developed a method to produce artificially grown miniature brains — called human brain organoids — free of animal cells that could greatly improve the way neurodegenerative conditions are studied and, eventually, treated.

Over the last decade of researching neurologic diseases, scientists have explored the use of human brain organoids as an alternative to mouse models. These self-assembled, 3D tissues derived from embryonic or pluripotent stem cells more closely model the complex brain structure compared to conventional two-dimensional cultures.

Until now, the engineered network of proteins and molecules that give structure to the cells in brain organoids, known as extracellular matrices, often used a substance derived from mouse sarcomas called Matrigel. That method suffers significant disadvantages, with a relatively undefined composition and batch-to-batch variability.

The latest U-M research, published in Annals of Clinical and Translational Neurology, offers a solution to overcome Matrigel’s weaknesses. Investigators created a novel culture method that uses an engineered extracellular matrix for human brain organoids — without the presence of animal components – and enhanced the neurogenesis of brain organoids compared to previous studies.

“This advancement in the development of human brain organoids free of animal components will allow for significant strides in the understanding of neurodevelopmental biology,” said senior author Joerg Lahann, Ph.D., director of the U-M Biointerfaces Institute and Wolfgang Pauli Collegiate Professor of Chemical Engineering at U-M.

“Scientists have long struggled to translate animal research into the clinical world, and this novel method will make it easier for translational research to make its way from the lab to the clinic.”

The foundational extracellular matrices of the research team’s brain organoids were comprised of human fibronectin, a protein that serves as a native structure for stem cells to adhere, differentiate and mature. They were supported by a highly porous polymer scaffold.

The organoids were cultured for months, while lab staff was unable to enter the building due to the COVID 19-pandemic.

Using proteomics, researchers found their brain organoids developed cerebral spinal fluid, a clear liquid that flows around healthy brain and spinal cords. This fluid more closely matched human adult CSF compared to a landmark study of human brain organoids developed in Matrigel.

“When our brains are naturally developing in utero, they are of course not growing on a bed of extracellular matrix produced by mouse cancer cells,” said first author AyÅŸe Muñiz, Ph.D., who was a graduate student in the U-M Macromolecular Science and Engineering Program at the time of the work.  

“By putting cells in an engineered niche that more closely resembles their natural environment, we predicted we would observe differences in organoid development that more faithfully mimics what we see in nature.”

The success of these xenogeneic-free human brain organoids opens the door for reprogramming with cells from patients with neurodegenerative diseases, says co-author Eva Feldman, M.D., Ph.D., director of the ALS Center of Excellence at U-M and James W. Albers Distinguished Professor of Neurology at U-M Medical School.

“There is a possibility to take the stem cells from a patient with a condition such as ALS or Alzheimer’s and, essentially, build an avatar mini brain of that patients to investigate possible treatments or model how their disease will progress,” Feldman said. “These models would create another avenue to predict disease and study treatment on a personalized level for conditions that often vary greatly from person to person.”

Additional authors include TuÄŸba Topal, Ph.D., Michael D. Brooks, Ph.D., Angela Sze, Do Hoon Kim, Jacob Jordahl, Ph.D., Joe Nguyen, Ph.D., Paul H. Krebsbach, D.D.S., Ph.D., Masha G. Savelieff, all of University of Michigan.

A.J.M. is funded by the National Science Foundation with grant no. DGE 1256260. E.L.F. thanks the Robert and Katherine Jacobs Health Environmental Initiative Fund, the Andrea and Lawrence A. Wolfe Brain Health Initiative Fund, Robert E. Nederlander Sr. Program for Alzheimer's Research, and NeuroNetwork for Emerging Therapies. We acknowledge funding from the University of Michigan Biointerfaces Institute (E.L.F. and J.L.).

Paper Cited: “Engineered extracellular matrices facilitate brain organoids from human pluripotent stem cells,” Annals of Clinical and Translational Neurology. DOI: 10.1002/acn3.51820

Timing of turkey nesting may not shift with changing climate


Peer-Reviewed Publication

NORTH CAROLINA STATE UNIVERSITY




A new study suggests eastern wild turkeys in five southern U.S. states are unlikely to make meaningful changes in the timing of when they begin nesting, even under significant future climate change.

The findings suggest eastern wild turkeys (Meleagris gallopavo silvestris) could be vulnerable to shifts in climate, which could threaten the availability of their food sources, the amount of vegetation cover available to protect them from predators, and other factors.

“There are implications here for turkey populations if individuals are inflexible in their ability to shift their reproductive activities, as resources are certainly going to change in the future,” said Chris Moorman, professor in North Carolina State University’s Fisheries, Wildlife and Conservation Biology Program. “This could result in ‘phenological mismatch,’ where the timing of an animal’s natural history doesn’t match up with the food and cover resources that are critical for successful reproduction and survival.”

After overhunting and habitat loss drove wild turkeys almost to extinction, the species is now common throughout North America. However, a recent survey reported wild turkey populations in the southeastern United States have been in decline since 2009. North Carolina has a stable population as estimated by hunting harvests, but some southern states have set hunting restrictions in an attempt to stop or reverse declines. Researchers acknowledge there are outstanding questions about the role of weather and climate change, emerging diseases, and other factors on turkeys.

“Turkeys are a highly adaptable species; this adaptability facilitated their ability to be restored,” said the study’s lead author Wesley Boone, a postdoctoral research scholar at NC State. “We want to know if they’re going to be able to persist in a future with a changing climate, and changing landscapes, too.”

To determine the impact of climate change on turkey nesting, researchers tracked when eastern wild turkeys began nesting in five states in the Southeast across eight years. Working under safety protocols, researchers used nets to capture female turkeys. They attached GPS transmitters to monitor the turkeys’ location remotely to identify patterns in their movements that indicated turkeys had started incubating their nests, which is when they sit on their eggs to keep them warm. They visited nests to confirm their location and to see if one or more eggs had hatched.

The researchers then used weather data gathered between 2014 and 2021 to see if temperature, rainfall, and the timing of “spring green-up” linked with the timing of when turkeys started nest incubation. They also projected whether turkey nest timing would shift by 2041-2060 under two climate-change scenarios.

When they analyzed the timing for 717 total nests and 186 “successful” nests that hatched at least one egg, researchers found that temperature and rainfall were associated with slight changes in when turkeys began nesting. However, the changes were so slight that they could be measured in hours, and not days.

When they looked at the relationship between climate change-related shifts in average precipitation and temperature changes, they found the timing of successful nests would change by less than three hours. The research team did not see any links between turkey nest timing and spring green-up.

“We did find relationships between nest timing, rainfall, and temperature, but when we projected that into the future, there is no biological relevance in the shift in timing,” Boone said. “However, the lack of change in response to a changing climate could be a problem because the critical food and cover resources linked with spring green-up are likely to shift earlier in the future.”

“For many animals, there is variability around the timing of breeding that would allow individuals to adapt to availability of resources,” Moorman said. “We did not project drastic changes in the timing of when wild turkeys nest under climate change. Turkeys seem relatively inflexible as to when they reproduce – nesting is initiated around the same time each year with only slight shifts in the timing, regardless of weather conditions.”

This is the first in a series of studies designed to understand the effects of climate change on reproduction of the eastern wild turkey. Future studies will explore other measures of turkey reproductive success, including whether temperature and precipitation affect the survival of turkey nests and the recently hatch young, which are called poults. The findings have implications for long-term turkey conservation, including the timing of hunting seasons.

“There could be a lot of factors interacting to cause declines, including timing of the hunting season, land-use change that impacts habitat, changes in predator populations, as well as weather, climate and diseases,” Boone said. “We need to begin chipping away at the questions to build a comprehensive understanding of the current and future threats to wild turkey population sustainability.”

The study, “Minimal shifts of eastern wild turkey nesting phenology associated with projected climate change,” was published online in Climate Change Ecology. Co-authors included Adam J. Terando of the U.S. Geological Survey Southeast Climate Adaptation Science Center; David J. Moscicki and Krishna Pacifici of NC State; Bret A. Collier of Louisiana State University and Michael J. Chamberlain of the University of Georgia. Funding was provided by the U.S. Geological Survey’s Southeast Climate Adaptation Science Center at NC State. Funding for field data collection was provided by the Georgia Department of Natural Resources Wildlife Resources Division; Louisiana Department of Wildlife and Fisheries; South Carolina Department of Natural Resources; U.S. Department of Agriculture Forest Service; Warnell School of Forestry and Natural Resources at the University of Georgia; the North Carolina Wildlife Resources Commission and National Wild Turkey Federation.

-oleniacz-

 

Note to Editors: The study abstract follows.

 

“Minimal shifts of eastern wild turkey nesting phenology associated with projected climate change”

 

Authors: Wesley W. Boone, Christopher E. Moorman, Adam J. Terando, David J. Moscicki, Bret A. Collier, Michael J. Chamberlain and Krishna Pacifici

 

Published: July 12, 2023, Climate Change Ecology

 

DOI10.1016/j.ecochg.2023.100075

 

Abstract: Climate change may induce mismatches between wildlife reproductive phenology and temporal occurrence of resources necessary for reproductive success. Verifying and elucidating the causal mechanisms behind potential mismatches requires large-scale, longer-duration data. We used eastern wild turkey (Meleagris gallopavo silvestris) nesting data collected across the southeastern U.S. over eight years to investigate potential climatic drivers of variation in nest initiation dates. We investigated climactic relationships with two datasets, one inclusive of successful and unsuccessful nests (full dataset) and another of just successful nests (successfully hatched dataset), to determine whether successfully hatched nests responded differently to weather changes than all nests did. In the full dataset, each 10 cm increase in January precipitation was associated with nesting occurring 0.46-0.66 days earlier, and each 10 cm increase in precipitation during the 30 days preceding nesting was associated with nesting occurring 0.17-0.21 days later. In the successfully hatched dataset, a 10 cm increase in March precipitation was associated with nesting occurring 0.67-0.74 days earlier, and an increase of one unit of variation in February maximum temperature was associated with nesting occurring 0.02 days later. We combined the results of these modeled relationships with multiple climate scenarios to understand potential implications of future climate change on wild turkey nesting phenology; results indicated that mean nest initiation date is projected to change by <0.1 day by 2040-2060. Wild turkey nesting phenology did not track changes in spring green-up timing, which could result in phenological mismatch between the timing of nesting and the availability of resources critical for successful reproduction.